Table 3. The models inheritance for -137G/C and -607C/A in HBV recurrence patients and nonrecurrence control subjects.
No | Yes | OR a(95% CI b) | P value | AIC c | BIC d | |
-137G/C Model | ||||||
Codominant | 0.44 | 82.6 | 91 | |||
G/G | 85 (78%) | 11 (91.7%) | 1.00 | |||
G/C | 22 (20.2%) | 1 (8.3%) | 0.35 (0.04–2.87) | |||
C/C | 2 (1.8%) | 0 (0%) | 0.00 (0.00–NA) | |||
Dominant | 0.22 | 80.7 | 86.3 | |||
G/G | 85 (78%) | 11 (91.7%) | 1.00 | |||
G/C-C/C | 24 (22%) | 1 (8.3%) | 0.32 (0.04–2.62) | |||
Recessive | 0.52 | 81.8 | 87.4 | |||
G/G-G/C | 107 (98.2%) | 12 (100%) | 1.00 | |||
C/C | 2 (1.8%) | 0 (0%) | 0.00 (0.00–NA) | |||
Overdominant | 0.28 | 81.1 | 86.7 | |||
G/G-C/C | 87 (79.8%) | 11 (91.7%) | 1.00 | |||
G/C | 22 (20.2%) | 1 (8.3%) | 0.36 (0.04–2.93) | |||
Log-additive | — | — | 0.33 (0.04–2.52) | 0.21 | 80.6 | 86.2 |
-607C/A Model | ||||||
Overdominant | 0.22 | 81.2 | 89.6 | |||
C/C | 37 (33.9%) | 3 (25%) | 1.00 | |||
C/A | 46 (42.2%) | 8 (66.7%) | 2.14 (0.53–8.66) | |||
A/A | 26 (23.9%) | 1 (8.3%) | 0.47 (0.05–4.82) | |||
Dominant | 0.52 | 81.8 | 87.4 | |||
C/C | 37 (33.9%) | 3 (25%) | 1.00 | |||
C/A-A/A | 72 (66.1%) | 9 (75%) | 1.54 (0.39–6.04) | |||
Recessive | 0.18 | 80.4 | 86 | |||
C/C-C/A | 83 (76.2%) | 11 (91.7%) | 1.00 | |||
A/A | 26 (23.9%) | 1 (8.3%) | 0.29 (0.04–2.36) | |||
Overdominant | 0.11 | 79.6 | 85.2 | |||
C/C-A/A | 63 (57.8%) | 4 (33.3%) | 1.00 | |||
C/A | 46 (42.2%) | 8 (66.7%) | 2.74 (0.78–9.65) | |||
Log-additive | — | — | 0.88 (0.39–2.00) | 0.77 | 82.1 | 87.7 |
a Odds ratio
b Confidence Interval
c Akaike’s information criterion
d Bayesian information criterion